Research

Personalized medicine with individually tailored therapies is becoming more and more a reality in cancer. This requires a precise look into the genetic material of tumors, a molecular diagnostic tumor profile. A research group from the German Network for Personalized Medicine (DNPM) has recorded the quality standards according to which genome analyses are carried out […]

Heidelberg, Germany, 24.09.2024 – RHEACELL today announced that the U.S. Food and Drug Administration (FDA) approved the companies blinded, multi-centric Phase-3 trial (NCT06489028) to investigate allo-APZ2-CVU in patients with chronic venous ulcers (CVU). Allo-APZ2-CVU is a first-in-class stem cell therapy leveraging ABCB5-positive mesenchymal stem cells (MSCs) to treat patients with severe immune and inflammation-driven diseases […]

We are pleased to announce significant news: the first sustainable and biodegradable pregnancy test in Europe developed by Zamann Pharma Support, under the Terra Trust house brand, has been nominated for the prestigious DQS Sustainability Award 2024 in the “Sustainable Innovation” category. This nomination is a confirmation of their tireless commitment to environmental protection and […]

The Helmholtz Association and the Stifterverband für die Deutsche Wissenschaft have awarded the biochemist Oliver Bruns (NCT/UCC Dresden and DKFZ) and the chemist Ellen Sletten (UCLA) with the Helmholtz High Impact Award 2024. Both are honored for their research on a new medical imaging technology in the short-wave infrared (SWIR) range, which has the potential […]

The new research team led by Dr. Stefanie Bärthel will work on developing next-generation immunotherapies by leveraging the antitumor effects of neutrophils. Heidelberg, September 17, 2024. BioMed X, a German biomedical research institute, announced the start of a new research team at the BioMed X Institute in Heidelberg, Germany, the institute’s first joint research project […]

Researchers have identified key cellular control sites that regulate gene expression and prevent the activation of ‘cryptic’ genomic regions, including ancient viral sequences Summary For any organism to survive and thrive, its cells must strictly control which genes are active when and where. New research from EMBL Heidelberg’s Noh Group and their collaborators from EMBL […]

Scientists collaborate to customise top-of-the-line microscopy method with AI to better understand glioblastoma brain tumours Summary Imagine building a traffic surveillance camera that could detect trouble-making cells speeding around in your brain before their cellular gang could commit ‘crimes’. Most importantly, this camera could catch some of the biggest interlopers of all – cancer cells. […]

Interdisciplinary research team uses DNA microbeads to control the development of cultivated tissue A new molecular engineering technique can precisely influence the development of organoids. Microbeads made of specifically folded DNA are used to release growth factors or other signal molecules inside the tissue structures. This gives rise to considerably more complex organoids that imitate […]

In recognition of his outstanding scientific achievements, Joachim Spatz, Managing Director of the Max Planck Institute for Medical Research in Heidelberg, honored Hendrik Dietz from the Technical University of Munich with the Institute’s Otto Meyerhof Medal. In a festive ceremony at the Max Planck Institute for Medical Research (MPImF) in Heidelberg, Joachim Spatz awarded the […]